These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6250982)

  • 21. [Cefotaxime in the treatment of severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Clumeck N; Van Laethem Y; Vanhoof R; Jaspar N; George G; Rapin M; Butzler JP
    Nouv Presse Med; 1981 Feb; 10(8):622-4. PubMed ID: 6259606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Dureux JB; Canton P; Roche G; Weber M; Gérard A
    Nouv Presse Med; 1981 Feb; 10(8):601-6. PubMed ID: 6259602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
    Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacokinetics of cefotaxim in geriatric patients (author's transl)].
    Naber K; Adam D
    MMW Munch Med Wochenschr; 1980 Nov; 122(46):1651-4. PubMed ID: 6258061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tissue concentration of ceftizoxime in the lung].
    Adam D; König J
    Arzneimittelforschung; 1983; 33(3):427-9. PubMed ID: 6307319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cefotaxime in digestive tract infections (author's transl)].
    Paris J; Paris JC; Gérard A
    Nouv Presse Med; 1981 Feb; 10(8):647-9. PubMed ID: 6259611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NONMEM analysis in determining the tri-exponential disposition of cefotaxime: a method of evaluating serum and urinary phase I data.
    Weber W; Harnisch L; Zimmer M; Rokitta C; Mendes P
    Int J Clin Pharmacol Ther; 1995 Oct; 33(10):560-4. PubMed ID: 8574507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical experience of cefotaxime (author's transl)].
    Portier H; Carbon C; Boussougant Y; Destaing F
    Nouv Presse Med; 1981 Feb; 10(8):607-11. PubMed ID: 6259603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Concentrations of cefotaxime in human tissues and fluids. A review of published data (author's transl)].
    Galy J; Mantel O
    Nouv Presse Med; 1981 Feb; 10(8):565-73. PubMed ID: 6259594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of Gram-negative septicaemia with cefotaxime: 16 cases (author's transl)].
    Goulon M; Gajdos P; Pilliot J
    Nouv Presse Med; 1981 Feb; 10(8):613-6. PubMed ID: 6259604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cefotaxime in the treatment of purulent meningitis in children (author's transl)].
    Borderon JC; Despert F; Santini JJ; Laugier J; Grenier B; Boulard P
    Nouv Presse Med; 1981 Feb; 10(8):634-8. PubMed ID: 6259609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experience with cefotaxime in gynecology and obstetrics.
    Takase Z
    Clin Ther; 1981; 4 Suppl A():25-44. PubMed ID: 6275996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Penetration of cefotaxime into bronchial secretions].
    Bergogne-Berezin E; Morel C; Pierre J; Monrocq N; Dournovo P; Benard Y
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):501-5. PubMed ID: 6289226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A study of prostatic tissue levels of cefodizime (CDZM)].
    Yamada Y; Fukatsu H; Kamijo A; Mizumoto H; Taki T; Mitsui K; Nonomura H; Ohshita H; Miyagawa Y; Hatano Y
    Hinyokika Kiyo; 1994 Apr; 40(4):365-9. PubMed ID: 7514846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cefotaxime in childhood infections (author's transl)].
    Garnier JM; Giraud F
    Nouv Presse Med; 1981 Feb; 10(8):629-33. PubMed ID: 6259608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cefotaxime in bronchopulmonary infections (author's transl)].
    Kermarec J; Sauvaget J
    Nouv Presse Med; 1981 Feb; 10(8):650-3. PubMed ID: 6259612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perioperative pharmacokinetics of cefotaxime in serum and bile during continuous and intermittent infusion in liver transplant patients.
    Buijk SE; Gyssens IC; Mouton JW; Metselaar HJ; Groenland TH; Verbrugh HA; Bruining HA
    J Antimicrob Chemother; 2004 Jul; 54(1):199-205. PubMed ID: 15175266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Concentration of cefamandole in human renal parenchyma (author's transl)].
    Kroening U; Brückner O; Nagel R
    Arzneimittelforschung; 1981; 31(11):1976-9. PubMed ID: 7198478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical experience with cefotaxime (HR-756) in surgical patients.
    Aznar J; Muñoz E; García-Iglesias MC; Perea EJ
    Methods Find Exp Clin Pharmacol; 1981; 3(3):183-7. PubMed ID: 6265719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacokinetic study of a cephalosporin: cefoperazone in patients with a Kehr drain].
    Farquet C; Marti MC; Balant L; Cochet B; Rudhardt M; Fabre J; Rohner A
    Schweiz Med Wochenschr; 1982 Jan; 112(4):123-9. PubMed ID: 6461067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.